Regulatory PathRegulatory requirements compared

Active substance

Gadoteric acid

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CLARISCAN0.5 mmol/mlSolution for injection · Intravenous use10 Pre-filled syringeSAR 1058.00NCE · PrescriptionGE Healthcare ASValid
CLARISCAN0.5 mmol/mlSolution for injection · Intravenous use10 Pre-filled syringeSAR 714.10Generic · PrescriptionGE Healthcare ASValid
CLARISCAN0.5 mmol/mlSolution for injection · Intravenous use10 Pre-filled syringeSAR 1265.05Generic · PrescriptionGE Healthcare ASValid
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION0.5 mmol/mlSolution for injection in pre-filled syringe · Intravenous use10 VialSAR 597.90Generic · PrescriptionGE Healthcare ASValid
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION0.5 mmol/mlSolution for injection in pre-filled syringe · Intravenous use10 VialSAR 885.80Generic · PrescriptionGE Healthcare ASValid
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION0.5 mmol/mlSolution · Intravenous use10 VialSAR 1138.55Generic · PrescriptionGE Healthcare ASValid
DOTAREM 0.5MOL-L GLASS BOTTLE W-STOPPER27.932 gSolution for injection · Intravenous use1 VialSAR 247.30Radiopharmaceutical · PrescriptionLABORATORIES GUERBETValid
DOTAREM 376MG-ML PREFILLED SYRINGE376 mmol/mlSuspension for injection in pre-filled syringe · Intravenous use1 Injection SyringeSAR 323.00Radiopharmaceutical · PrescriptionLABORATORIES GUERBETValid
DOTAREM 376MG-ML PREFILLED SYRINGE376 mmol/mlSuspension for injection in pre-filled syringe · Intravenous use1 Injection SyringeSAR 398.35Radiopharmaceutical · PrescriptionLABORATORIES GUERBETValid
Dotagraf 0.5 mmol/ml Solution for Injection0.5 mmol/mlSolution for injection · Intravenous use1 VialSAR 59.80Generic · PrescriptionBAYER AGValid
Dotagraf 0.5 mmol/ml Solution for Injection0.5 mmol/mlSolution for injection · Intravenous use1 VialSAR 109.60Generic · PrescriptionBAYER AGValid

Combinations containing Gadoteric acid

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.